Pfizer (PFE) and Ligand Pharmaceuticals (LGND) announce the FDA has accepted for review a New...

|About: Pfizer Inc. (PFE)|By:, SA News Editor

Pfizer (PFE) and Ligand Pharmaceuticals (LGND) announce the FDA has accepted for review a New Drug Application for bazedoxifene/conjugated estrogens, a potential treatment for women with moderate-to-severe vasomotor symptoms and vulvar and vaginal atrophy associated with menopause, as well as the prevention of postmenopausal osteoporosis.